Early Fetal Growth Restriction with or Without Hypertensive Disorders: a Clinical Overview

Federico Mecacci1, Eleonora Romani1, Sara Clemenza2

  • 1Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Florence, Italy.

Insights

Early-onset fetal growth restriction (FGR) with hypertensive disorders of pregnancy (HDP) may lead to worse outcomes than FGR without HDP. This review compares clinical features, perinatal results, and long-term effects of these conditions.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Neonatology

Background:

  • Early onset fetal growth restriction (FGR) is a significant pregnancy complication linked to adverse neonatal outcomes.
  • It frequently co-occurs with early onset hypertensive disorders of pregnancy (HDP), particularly preeclampsia (PE).

Purpose of the Study:

  • To compare clinical characteristics, perinatal outcomes, and long-term sequelae between early onset FGR with HDP (FGR-HDP) and normotensive FGR (n-FGR).
  • To investigate if the presence of PE exacerbates maternal hemodynamic impairment and placental issues in early onset FGR.

Main Methods:

  • This is a review article, synthesizing existing data on early onset FGR-HDP and n-FGR.
  • The review compares clinical presentations, perinatal outcomes, and potential long-term effects based on current literature.

Main Results:

  • Emerging data suggest PE may worsen maternal hemodynamics and placental pathology in early onset FGR.
  • Pregnancies with FGR-HDP may face increased risks for poor neonatal outcomes compared to those with n-FGR.

Conclusions:

  • Distinguishing between FGR-HDP and n-FGR is crucial for tailored management and follow-up.
  • Further research is needed to fully elucidate the distinct impacts and optimal care strategies for these conditions.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
980
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
185
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16